Acute Dialysis Quality Initiative 4 th International Consensus Conference

Acute Dialysis Quality Initiative 3 rd International Consensus Conference

Current status of renal and urinary proteomics: ready for routine clinical application?

4. Newsome BB, Warnock DG, McClellan WM et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 2008; 168: 609–616 5. Coca SG, Yusuf B, Shlipak MG et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic rev...

Acute Dialysis Quality Initiative 4 th International Consensus Conference Workgroup

Secondary renal injury in the setting of acute renal failure (ARF) is “an additional renal injury developing in the setting of a primary renal injury”. The nature of prevention of secondary renal injury in the setting of ARF may depend on the process initiating primary renal injury. It is often impossible to separate primary from secondary renal injury when the process of primary acute renal in...

Acute Dialysis Quality Initiative 4 th International Consensus Conference

Iatrogenic acute kidney injury can be defined as acute kidney injury (AKI) that is directly or indirectly due to medical (therapeutic or diagnostic) interventions. This definition does not imply that iatrogenic AKI is always preventable. Indeed, sometimes the need for the medical intervention outweighs the risk of causing kidney dysfunction. On the other hand, in many circumstances iatrogenic r...

Current Use of Biomarkers in Acute Kidney Injury: Report and Summary of Recommendations from the 10th Acute Dialysis Quality Initiative Consensus Conference

Over the last decade there has been considerable progress in the discovery and development of biomarkers of kidney disease, and several have now been evaluated in different clinical settings. Although there is a growing literature on the performance of various biomarkers in clinical studies, there is limited information on how these biomarkers would be utilized by clinicians to manage patients ...